11Feb 2023
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real‐world findings from NHS England between 2013 and 2019

Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real‐world findings from NHS England between 2013 and 2019

The study reports NHS England data for patients with bladder cancer (BC), upper tract urothelial cancer (UTUC), and urethral cancers from 2013 to 2019. Incidence rates were stable. About 41.3% of patients were referred outside the 2‐week‐wait pathway, and 12.2% presented as emergencies. Surgery, radiotherapy, chemotherapy, or multimodal treatment use varied with disease stage, patient factors and Cancer Alliance. Between 27% and 29% of muscle‐invasive BCs did not receive radical treatment. Overall survival rates did not improve over time at 2 years in contrast to other cancers. NHS Digital data offers a population‐wide picture of this disease but does not allow individual outcomes to be matched with disease or patient features, and key parameters can be missing or incomplete.

  • #urology

Like

Save

Share